Упрощенная HTML-версия
139
104.
Guidelines for the management of adult lower respiratory tract infections
/ M.A. Woodhead [et al.] // Eur. Respir. J. – 2005. – Vol. 26. – P. 1138-1180.
105.
Guthrie R. Community-acquired lower respiratory tract infections.
Etiology and treatment / R. Guthrie // Chest. – 2001. - № 120. – P. 2021-2034.
106.
Gutteridge J.M. Free radicals and antioxidants in the year 2000. A
historical look to the future / J.M. Gutteridge, В. Halliwell // Ann. N.Y. Acad. Sci. –
2000. – Vol. 899. – P. 136-147.
107.
Hugh A. Severe pneumonia in the elderly: risks, treatment, and
prevention / A. Hugh // Medscape Respir. Care. – 1998. - № 2(2).
108.
Incidence of community-acquired pneumonia requiring hospitalization.
Results of a population-based active surveillance Study in Ohio. The Community-
Based Pneumonia Incidence Study Group / B.J. Marston [et al.] // Arch. Intern. Med.
– 1997. – Vol. 157. – P. 1709-1918.
109.
Is azithromycin the first-choice macrolide for treatment of community-
acquired pneumonia? / F. Sanchez [et al.] // Clin. Infect. Dis. – 2003. – Vol. 36. – P.
1239-1245.
110.
Johnson J.L. Slowly resolving and nonresolving pneumonia. Questions
to ask when response is delayed / J.L. Johnson // Postgrad. Med. – 2000. – Vol. 108.
– P. 113-123.
111.
Kaplan V. Hospitalized community-acquired pneumonia in the elderly /
V. Kaplan, W.T. Linde-Zwirble [et al.] // Am. J. Respir. Crit. Care Med. – 2002. –
Vol. 165, № 6. – P. 766-772.
112.
Keeley D. Guidelines for managing community-acquired pneumonia in
adults / D. Keeley // BMJ. – 2002. – Vol. 324. – P. 436-437.
113.
Kemp K. Pneumococcal infections in humans are associated with
increased apoptosis and trafficking of type 1 cytokine- producing T cells / K. Kemp,
H. Bruunsgaard [et al.] // Infect. Immun. – 2002. – Vol. 70, № 9. – P. 5019-5025.
114.
Kirtland S.H. Slowly resolving, chronic and recurrent pneumonia / S.H
Kirtland, R.H. Winterbauer // Clin. Chest Med. – 1991. - Vol. 12. – P. 303-318.